Former pharmaceutical executive Martin Shkreli, who is awaiting sentencing on three convicted counts in a securities fraud case, is on the hook for almost $10.5 million in losses to his investors, a federal judge has found.
Shkreli was convicted in August of two counts of securities fraud and a related conspiracy charge following a five-week trial, and was acquitted of five other charges.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]